Biomedical Sciences

• Email the School
• General Inquiries

Prof Lexin Wang is an academic cardiologist specializing cardiovascular pharmacology and cardiac electrophysiology. After completing his training in clinical cardiology and cardiac electrophysiology at Peking Union Medical College and Royal Perth Hospital, he worked as a physician and academic at the First Hospital of Peking University and the University of Tasmania School of Medicine, respectively. He jointed CSU in 1998 to initiate pharmacology and therapeutics programs, which now serve several courses in the Faculty of Science.

    Prof Wang is the head of CSU Cardiovascular Research, a multidisciplinary research group investigating new diagnostic and therapeutic techniques in cardiovascular disease and stroke. He is an elected Fellow of the Cardiac Society of Australia and New Zealand. He also holds adjunct appointments in several Australian and Chinese universities, such as Clinical Professor at the Cardiology Unit, Macquarie University, Honorary Professor and Director of the Department of Cardiology at Taishan Medical College. He is a recipient of the CSU Vice-Chancellor???s Award for Research Excellence in 2002 and 2006.

Teaching

Current subjects taught

• PHM430 Therapeutics
• BMS 301 Medical Science Special Topics
• BMS335 Clinical Cardiovascular Physiology
  

Research

Research interests are centered on the management of heart failure, hypertension, coronary artery disease, stroke and novel keyhole cardiac surgeries.

Current projects include: 

1)T wave alternans in predicting  sudden cardiac death in patients with heart failure;

2)Stem cell therapies for stroke; and

3) thoracoscopic repair of congenital cardiac defects in children and young adults

Publications

An author of more than 250 peer-reviewed articles in major national and international journals, and a co-author of two major cardiology textbooks.

Ten recent publications are listed as below:

1. Ma ZS, Dong MF, Yin QY, Feng ZY, Wang LX. Totally thoracoscopic repair of ventricular septal defect without robotically-assisted surgical system. Journal of Thoracic and Cardiovascular Surgery 2011 (in press)

2. Xiong X, You C, Feng QC, Yin T, Yang SH, Xie PC, Chen ZB, Wang LX. Pulse width modulation electro-acupuncture on cardiovascular remodelling and plasma nitric oxide in spontaneously hypertensive rats. Evidence Based Complementary and Alternative Medicine doi:10.1093/ecam/neq063

3. Ma ZS, Dong MF, Yin QY, Feng ZY, Wang LX. Totally thoracoscopic repair of atrial septal defect without robotic assistance: a single center experience. Journal of Thoracic and Cardiovascular Surgery DOI: 10.1016/j.jtcvs.2010.10.028

4. Wang L, Liu GJ, Chen YX, Dong HP, Zhang YQ, Wang LX. Combined use of P-selectin and D-dimer in the diagnosis of portal vein thrombosis following splenectomy. Thrombosis Research 2010; 125:e206-e209.

5. Chen QJ, Zhang MZ, Wang LX. Gensenoside Rg3 inhibits hypoxia-induced VEGF expression in human cancer cells. Cellular Physiology and Biochemistry 2010; 26:849-858.

6. He SW, Wang LX. Impact of anaemia on the outcomes of chronic heart failure: a meta-analysis and systemic review. Congestive Heart Failure 2009; 15(3):123-130.

7. Liu JZ, Chen SG, Zhang B, Wang CB, Zhao XW, Li GY, Wang LX. Effect of Haishengsu as an adjunct therapy for patients with advanced renal cell carcinoma: A randomized and placebo-controlled clinical trial. The Journal of Alternative and Complementary Medicine 2009, 15(10): 1127-1130.

8. Wu TG, Zhao Q, Huang WG, Wei JR, Chen SW, Zhao J, Huang LP, Wang LX. Effect of intracoronary tirofiban in patients undergoing percutaneous coronary intervention for acute coronary syndrome.  Circulation Journal 2008; 72(10):1605-1609.

9. Zhang YZ, Xing XW, He B, Wang LX. Effects of testosterone on cytokines and left ventricular remodeling following heart failure. Cellular Physiology and Biochemistry 2007; 20:847-852.

10. Wei TM, Zeng CL, Chen LP, Chen QY, Zhao RY, Lu GX, Lu CL, Wang LX. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. European Journal of Heart Failure 2005; 7(1):75-79.

Professional:

Fellow, the Cardiac Society of Australia and New Zealand (CSANZ)